So, who is getting all those free drug samples, anyway? The poor, or the wealthy insured? A recent study puts this to the test.
Some refreshing candor – Novartis CEO Dan Vasella admits that he uses Lipitor (Pfizer‘s cholesterol drug) instead of Novartis’ Lescol. Medical responsibility triumphs over marketing spin!
Prasugrel, a promising Lilly/Daiichi Sankyo drug, is about to be submitted to the FDA. This will be an interesting one – the drug has blockbuster potential, but will it be fast-tracked – or side-tracked?
Very promising new Hepatitis B treatment may be on the horizon.
Sciele gets approval for new formulations of its Sular HBP drug.
Mylan gets the OK to market a generic version of Zyrtec.
Who needs sleep? Just snort the latest sleep-replacement chemical!
BD gets the go-ahead for a rapid staph test, quickly identifying the presence of antibiotic-resistant strains.